These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 15823453

  • 1. Rapid onset of tolerance to beta-agonist bronchodilation.
    Haney S, Hancox RJ.
    Respir Med; 2005 May; 99(5):566-71. PubMed ID: 15823453
    [Abstract] [Full Text] [Related]

  • 2. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.
    Haney S, Hancox RJ.
    Respir Res; 2005 Sep 16; 6(1):107. PubMed ID: 16168062
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I, Hall IP, McFarlane LC, Lipworth BJ.
    J Allergy Clin Immunol; 1998 Mar 16; 101(3):337-41. PubMed ID: 9525449
    [Abstract] [Full Text] [Related]

  • 5. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ, Winter TH, Aalbers R.
    Thorax; 2001 Jul 16; 56(7):529-35. PubMed ID: 11413351
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Salbutamol tolerance to bronchoprotection: course of onset.
    Stewart SL, Martin AL, Davis BE, Cockcroft DW.
    Ann Allergy Asthma Immunol; 2012 Dec 16; 109(6):454-7. PubMed ID: 23176887
    [Abstract] [Full Text] [Related]

  • 8. Cross tolerance to salbutamol occurs independently of beta2 adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol.
    Lee DK, Jackson CM, Bates CE, Lipworth BJ.
    Thorax; 2004 Aug 16; 59(8):662-7. PubMed ID: 15282385
    [Abstract] [Full Text] [Related]

  • 9. Effects of treatment with formoterol on bronchoprotection against methacholine.
    Lipworth B, Tan S, Devlin M, Aiken T, Baker R, Hendrick D.
    Am J Med; 1998 May 16; 104(5):431-8. PubMed ID: 9626025
    [Abstract] [Full Text] [Related]

  • 10. Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment.
    Yates DH, Sussman HS, Shaw MJ, Barnes PJ, Chung KF.
    Am J Respir Crit Care Med; 1995 Oct 16; 152(4 Pt 1):1170-4. PubMed ID: 7551366
    [Abstract] [Full Text] [Related]

  • 11. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
    Rosenborg J, Larsson P, Rott Z, Böcskei C, Poczi M, Juhász G.
    Eur J Clin Pharmacol; 2002 Jul 16; 58(4):S61-7. PubMed ID: 12214580
    [Abstract] [Full Text] [Related]

  • 12. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
    Kalra S, Swystun VA, Bhagat R, Cockcroft DW.
    Chest; 1996 Apr 16; 109(4):953-6. PubMed ID: 8635376
    [Abstract] [Full Text] [Related]

  • 13. Formoterol induces tolerance to the bronchodilating effect of Salbutamol following methacholine-provocation test in asthmatic children.
    Adler A, Uziel Y, Mei-Zahav M, Horowitz I.
    Pulm Pharmacol Ther; 2006 Apr 16; 19(4):281-5. PubMed ID: 16169761
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of inhaled formoterol in reversing bronchoconstriction.
    Rubin AS, Perin C, Pelegrin L, Fernandes JC, da Silva LC.
    J Bras Pneumol; 2006 Apr 16; 32(3):202-6. PubMed ID: 17273608
    [Abstract] [Full Text] [Related]

  • 15. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
    Yates DH, Worsdell M, Barnes PJ.
    Am J Respir Crit Care Med; 1997 Sep 16; 156(3 Pt 1):988-91. PubMed ID: 9310023
    [Abstract] [Full Text] [Related]

  • 16. Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol.
    Jones SL, Cowan JO, Flannery EM, Hancox RJ, Herbison GP, Taylor DR.
    Eur Respir J; 2001 Mar 16; 17(3):368-73. PubMed ID: 11405513
    [Abstract] [Full Text] [Related]

  • 17. Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group.
    FitzGerald JM, Chapman KR, Della Cioppa G, Stubbing D, Fairbarn MS, Till MD, Brambilla R.
    J Allergy Clin Immunol; 1999 Mar 16; 103(3 Pt 1):427-35. PubMed ID: 10069876
    [Abstract] [Full Text] [Related]

  • 18. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
    Cheung D, Timmers MC, Zwinderman AH, Bel EH, Dijkman JH, Sterk PJ.
    N Engl J Med; 1992 Oct 22; 327(17):1198-203. PubMed ID: 1357550
    [Abstract] [Full Text] [Related]

  • 19. Prolonged protection against methacholine-induced bronchoconstriction by the inhaled beta 2-agonist formoterol.
    Ramsdale EH, Otis J, Kline PA, Gontovnick LS, Hargreave FE, O'Byrne PM.
    Am Rev Respir Dis; 1991 May 22; 143(5 Pt 1):998-1001. PubMed ID: 1673830
    [Abstract] [Full Text] [Related]

  • 20. A comparison of salmeterol and formoterol in attenuating airway responses to short-acting beta2-agonists.
    van Veen A, Weller FR, Wierenga EA, Jansen HM, Jonkers RE.
    Pulm Pharmacol Ther; 2003 May 22; 16(3):153-61. PubMed ID: 12749831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.